about
GLP-1-based strategies: a physiological analysis of differential mode of actionAssociations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunityThe transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiolMutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions.Protective role of uncoupling protein 2 in atherosclerosis.High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogensDefective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.Estrogens and atherosclerosis.From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause.Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.Association of environmental markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life exposures and lifestyle in a case-control study.Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study.Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study.Understanding the oestrogen action in experimental and clinical atherosclerosis.Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing SEstrogen receptors and endothelium.Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?Diabetes and oral contraception.From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.Urinary and genital infections in patients with diabetes: How to diagnose and how to treat.Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp.Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity.Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications.Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes.[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].[Use of local estrogenotherapy in urology and pelviperineology: A systematic review].Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium.17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo.Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice.Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers.The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice.Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation.Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells.
P50
Q26997149-334EF5E1-4ED3-4FCC-89CA-DD1E99C27D60Q30397725-84E0037F-8939-4C28-B16C-4B358EBB1320Q30478113-2575A36B-B888-4BCB-818B-7AF18FA4D0DFQ30486064-09CEE9B7-BD55-481B-A3C3-D8CDE795E8D8Q30565938-46B68CA9-B64E-468C-947E-1F51ACE4186DQ33963991-2F02EDB2-8F25-4BE6-A52E-F0B266F823FCQ34469634-F235BB75-B56C-45BC-B960-3894D5DBC825Q34661745-3855E657-E405-48A6-AE8D-811181ECA484Q34880427-A96FB117-0C20-458D-ACBF-B88558100A5CQ35649223-C5BD7FDB-6432-4FF0-B45E-28D8BB8501ACQ35657905-FC9AFB75-EDC7-408F-B409-45DC217143BBQ35761199-6621E539-B225-4628-9B47-8681698E204BQ36131503-CF2671ED-C7EA-49C4-A9A0-D8D1FBEED63CQ36147370-7519814A-B864-4FE1-81B5-24E1A571891EQ36158841-2C16B845-9D68-4BD9-987D-54202E5451B1Q36193997-BC3DD94B-BD88-417A-B51F-A78F6C5CB166Q36655236-28F96A2F-59BF-4864-904B-7DC818BC7781Q37699691-5E9003C4-3C55-4AFE-918A-F6C3C35A5356Q37772711-1B6AA9FD-0F27-4300-BE3B-DE3F7FFA519AQ37822051-11B71B0C-9F7C-4EC8-82E2-AA237919741CQ38079349-301D63A4-3DB3-4327-822E-D2284E55F6D1Q38564128-D877668D-E6A8-4299-93DE-F66E7B41E01BQ38577493-51F79A63-A9B2-40B9-BC9B-A9656364B302Q38691457-FDA9EB0F-C47E-4B98-A937-590836EE7DFBQ38820528-B3770365-B8A3-4021-A494-F5CDFDE9D5A3Q38901991-C675ABB7-FBF3-4DEF-B4EB-6F6FF7E879EEQ39327184-4EBC3EE4-ABBF-48DC-A1E2-A3E4AD8A8501Q41198632-882A01B0-3256-4A40-9238-B1063D57D581Q41478622-08B699D7-D55F-4BB4-AFC0-67B2A9FA5B7DQ41483239-A35FB3F0-E0A7-4688-9D21-26DBA8369129Q41883424-C3C37A0D-3B41-4A6D-BDED-63956160EC15Q42435363-16642CE2-F0AB-411B-83AA-167F6FE8AA08Q43016733-1D3D779F-8834-4B78-84F9-D7A22F29039DQ43227364-D270C515-AE67-4E3E-B612-36E3A408A872Q43545481-8B9A28CA-3BF1-4477-B1A1-1AE94E7DFA70Q43635402-D629F868-EE2C-4A7F-BC4D-905E254A30A3Q44081111-27A782B9-DB40-4552-B001-F4D7497410A9Q44249441-3382A73E-8407-43DC-B8E9-0F84C852725EQ44836533-699E4E69-8A5D-4411-BF75-DA410C9B86B0Q45071109-06A337EC-1E46-4938-9EA5-24CA2063CE28
P50
description
Forscher
@de
chercheur
@fr
forsker
@nb
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
P. Gourdy
@ast
P. Gourdy
@nl
Pierre Gourdy
@en
Pierre Gourdy
@es
Pierre Gourdy
@nb
type
label
P. Gourdy
@ast
P. Gourdy
@nl
Pierre Gourdy
@en
Pierre Gourdy
@es
Pierre Gourdy
@nb
altLabel
P. Gourdy
@en
prefLabel
P. Gourdy
@ast
P. Gourdy
@nl
Pierre Gourdy
@en
Pierre Gourdy
@es
Pierre Gourdy
@nb
P1153
6603031545
P31
P496
0000-0002-5362-3813